• Je něco špatně v tomto záznamu ?

The effects of the treatment conditions on the dissolution profile of ethylcellulose coated pellets

S. Pavloková, J. Muselík, D. Sabadková, S. Bernatová, O. Samek, D. Neumann, A. Franc,

. 2019 ; 132 (-) : 86-95. [pub] 20190228

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19034743

Due to the additional particle coalescence in the coating, changes in the dissolution profile occur over time in the formulations coated by aqueous ethylcellulose latex. Dry thermal treatment (DT) of the coating can be used as a prevention of this process. Alternatively, it is advisable to take advantage of the synergistic effect of high humidity during wet treatment (WT), which substantially accelerates the film formation. This can be a problem for time-controlled systems, which are based on the coating rupture due to the penetration of water into the core causing the increase in the system volume. This process can begin already during the WT, which may affect the coating adversely. The submitted work was focused on the stability testing of two pellet core compositions: pellets containing swelling superdisintegrant sodium carboxymethyl starch (CMS) and pellets containing osmotically active polyethylene glycol (PEG). Another objective was to identify the treatment/storage condition effects on the pellet dissolution profiles. These pellets are intended to prevent hypoglycemia for patients with diabetes mellitus and therefore, besides the excipients, pellet cores contain 75% or 80% of glucose. The pellet coating is formed by ethylcellulose-based latex, which provides the required lag time (120-360 min). The sample stability was evaluated depending on the pellet core composition (PEG, CMS) for two types of final pellet coating treatment (DT or WT). Scanning electron microscopy and Raman microspectroscopy revealed the penetration of glucose and polyethylene glycol from the core to the PEG pellet surface after WT. For the CMS sample, significant pellet swelling after WT (under the conditions of elevated humidity) was statistically confirmed by the means of stereomicroscopic data evaluation. Therefore, the acceleration of dissolution rate during the stress tests is caused by the soluble substance penetration through the coating in the case of PEG pellets or by dosage form volume increase in the case of CMS pellets. The observed mechanisms can be generally anticipated during the stability testing of the ethylcellulose coated dosage forms. The aforementioned processes do not occur after DT and the pellets are stable in the environment without increased humidity.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19034743
003      
CZ-PrNML
005      
20191011105645.0
007      
ta
008      
191007s2019 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejps.2019.02.034 $2 doi
035    __
$a (PubMed)30825510
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Pavloková, Sylvie $u Department of Pharmaceutics, University of Veterinary and Pharmaceutical Sciences, Palackeho tr. 1946/1, 612 42 Brno, Czech Republic.
245    14
$a The effects of the treatment conditions on the dissolution profile of ethylcellulose coated pellets / $c S. Pavloková, J. Muselík, D. Sabadková, S. Bernatová, O. Samek, D. Neumann, A. Franc,
520    9_
$a Due to the additional particle coalescence in the coating, changes in the dissolution profile occur over time in the formulations coated by aqueous ethylcellulose latex. Dry thermal treatment (DT) of the coating can be used as a prevention of this process. Alternatively, it is advisable to take advantage of the synergistic effect of high humidity during wet treatment (WT), which substantially accelerates the film formation. This can be a problem for time-controlled systems, which are based on the coating rupture due to the penetration of water into the core causing the increase in the system volume. This process can begin already during the WT, which may affect the coating adversely. The submitted work was focused on the stability testing of two pellet core compositions: pellets containing swelling superdisintegrant sodium carboxymethyl starch (CMS) and pellets containing osmotically active polyethylene glycol (PEG). Another objective was to identify the treatment/storage condition effects on the pellet dissolution profiles. These pellets are intended to prevent hypoglycemia for patients with diabetes mellitus and therefore, besides the excipients, pellet cores contain 75% or 80% of glucose. The pellet coating is formed by ethylcellulose-based latex, which provides the required lag time (120-360 min). The sample stability was evaluated depending on the pellet core composition (PEG, CMS) for two types of final pellet coating treatment (DT or WT). Scanning electron microscopy and Raman microspectroscopy revealed the penetration of glucose and polyethylene glycol from the core to the PEG pellet surface after WT. For the CMS sample, significant pellet swelling after WT (under the conditions of elevated humidity) was statistically confirmed by the means of stereomicroscopic data evaluation. Therefore, the acceleration of dissolution rate during the stress tests is caused by the soluble substance penetration through the coating in the case of PEG pellets or by dosage form volume increase in the case of CMS pellets. The observed mechanisms can be generally anticipated during the stability testing of the ethylcellulose coated dosage forms. The aforementioned processes do not occur after DT and the pellets are stable in the environment without increased humidity.
650    _2
$a celulosa $x analogy a deriváty $x chemie $7 D002482
650    _2
$a chemie farmaceutická $7 D002626
650    _2
$a léky s prodlouženým účinkem $7 D003692
650    _2
$a příprava léků $x metody $7 D004339
650    _2
$a léky implantované $x chemie $7 D004343
650    _2
$a uvolňování léčiv $7 D065546
650    _2
$a stabilita léku $7 D004355
650    _2
$a pomocné látky $x chemie $7 D005079
650    _2
$a glukosa $x chemie $x farmakologie $7 D005947
650    _2
$a vysoká teplota $7 D006358
650    _2
$a hypoglykemie $x prevence a kontrola $7 D007003
650    _2
$a velikost částic $7 D010316
650    _2
$a polyethylenglykoly $x chemie $7 D011092
650    _2
$a rozpustnost $7 D012995
650    _2
$a škrob $x analogy a deriváty $x chemie $7 D013213
650    _2
$a povrchové vlastnosti $7 D013499
655    _2
$a časopisecké články $7 D016428
700    1_
$a Muselík, Jan $u Department of Pharmaceutics, University of Veterinary and Pharmaceutical Sciences, Palackeho tr. 1946/1, 612 42 Brno, Czech Republic. Electronic address: muselikj@vfu.cz.
700    1_
$a Sabadková, Dana $u Department of Pharmaceutics, University of Veterinary and Pharmaceutical Sciences, Palackeho tr. 1946/1, 612 42 Brno, Czech Republic.
700    1_
$a Bernatová, Silvie $u Institute of Scientific Instruments (ISI), Czech Academy of Sciences, v.v.i., Kralovopolska 147, 612 64 Brno, Czech Republic.
700    1_
$a Samek, Ota $u Institute of Scientific Instruments (ISI), Czech Academy of Sciences, v.v.i., Kralovopolska 147, 612 64 Brno, Czech Republic.
700    1_
$a Neumann, David $u Department of Pediatrics, Faculty of Medicine in Hradec Kralove, Charles University in Prague, University Hospital Hradec Kralove, Czech Republic.
700    1_
$a Franc, Aleš $u Department of Pharmaceutics, University of Veterinary and Pharmaceutical Sciences, Palackeho tr. 1946/1, 612 42 Brno, Czech Republic.
773    0_
$w MED00001639 $t European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences $x 1879-0720 $g Roč. 132, č. - (2019), s. 86-95
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30825510 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191011110105 $b ABA008
999    __
$a ok $b bmc $g 1451403 $s 1073293
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 132 $c - $d 86-95 $e 20190228 $i 1879-0720 $m European journal of pharmaceutical sciences $n Eur. j. pharm. sci. (Print) $x MED00001639
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...